Menu
Search

Tag archives: abbott

Abbott announced its participation in the 5th China International Import Expo (CIIE) in Shanghai on Wednesday, which marked the 100-day countdown to the annual expo that is scheduled to take place from Nov 5-10. Abbott, which will be making its third appearance at CIIE, is set to showcase its innovations in diagnostics, medical devices, nutrition products, and established pharmaceuticals under the theme "human-powered technology, shaping the future of health" at its 550-square-meter pavilion, according to a statement from the US-based global healthcare company. "CIIE is a platform of communication and exchanges. Participating in CIIE enables us to expand the reach

BEIJING - China"s customs has issued a statement advising consumers to stop buying and ingesting certain infant formulas produced by the US-based health-care company Abbott Nutrition. The US Food and Drug Administration (FDA) recently launched an investigation into the baby formulas following complaints of Cronobacter sakazakii and Salmonella Newport infections, said the General Administration of Customs (GAC), citing an FDA announcement. All of the cases are reported to have consumed powdered infant formula produced from Abbott Nutrition's Sturgis, Michigan facility. The brands are Similac, Alimentum and EleCare, according to the statement. The GAC said it will continue to closely follow

World-leading pharmaceutical and medical device companies are displaying their latest innovations at the fourth China International Import Expo with the hope that the expo can help these products gainer quicker approval for use in the Chinese market. GlaxoSmithKline is showcasing Mepolizumab, the world"s first interleukin-5 monoclonal antibody, which has received approval in several countries, including the United States, for treatment on patients with inflammatory diseases caused by the presence of an abnormally increased number of eosinophils in the blood. "The innovative therapy can significantly lower the recurrence rate of inflammatory diseases. Riding on the CIIE's 'spillover effect', we hope this